前性队列研究评估efgartigimod在中国泛性肌痛性肌痛症患者的疗效和安全性
Pan Wang1, Bo Zhang1, Jian Yin2
1Department of Neurology, Hainan General Hospital, Hainan Affiliated Hospital of Hainan Medical University, Haikou, China.
Frontiers in neurology
|July 5, 2024
概括
在中国患者中,Efgartigimod治疗显示出显著的疗效和良好的耐受性,这些患者患有一般化肌痛性肌痛症 (gMG). 单一循环改善了日常生活活动和肌肉力量,没有发现新的安全问题.
科学领域:
- 神经学 神经学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 在全球ADAPT试验中确定了efgartigimod的有效性.
- 缺乏关于中国参与者患有一般化肌痛性肌痛症 (gMG) 的具体数据.
- 需要在中国gMG群体中评估efgartigimod.
研究的目的:
- 评估efgartigimod在被诊断为gMG的中国患者中的疗效.
- 评估efgartigimod在这个人群中的安全性和耐受性.
主要方法:
- 在8家中国医院进行前性队列研究.
- 14gMG患者每周接受静脉注射efgartigimod (10mg/kg) 持续8周.
- 主要结局:4周内MG日常生活活动 (MG-ADL) 评分的变化;对不良事件 (AE) 的安全监测.
主要成果:
- 在第4周,MG-ADL得分显著平均减少6分.
- 85.7%的患者在一轮治疗后达到MG-ADL响应者状态.
- 量化MG (QMG) 评分平均下降7分;改善持续到第8周,没有报告的SAE或感染.
结论:
- 在中国的gMG患者中,单一循环的efgartigimod有效.
- 埃夫加蒂格莫德在8周内表现出良好的耐受性.
- 在这个队列中没有观察到新的安全信号.
更多相关视频
06:34A Component-resolved Diagnostic Approach for a Study on Grass Pollen Allergens in Chinese Southerners with Allergic Rhinitis and/or Asthma
Published on: June 4, 2017
10.0K
06:57Author Spotlight: Adjuvant Activity of Mycobacterium paratuberculosis in Enhancing the Immunogenicity of Autoantigens During Experimental Autoimmune Encephalomyelitis
Published on: May 12, 2023
2.1K
相关概念视频
01:20Myasthenia Gravis: Overview and Treatment
1.3K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.3K
01:15Myasthenia Gravis: Diagnostic Tests
753
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
753